Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
08 February 2021Website:
http://trisaluslifesci.comNext earnings report:
30 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Wed, 26 Jun 2024 20:00:00 GMTDividend
Analysts recommendations
Institutional Ownership
TLSI Latest News
WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences® Inc. (“TriSalus” or the “Company”) (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, announced today the expiration and results of its previously announced exchange offer (the “Offer”) and consent solicitation (the “Consent Solicitation”) relating to its warrants (the “Warrants”) identified in the Prospectus/Offer to Ex.
DENVER--(BUSINESS WIRE)--TriSalus Life Sciences® Inc. (“TriSalus” or the “Company”) (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, announced today that it has commenced an exchange offer (the “Offer”) and consent solicitation (the “Consent Solicitation”) relating to its warrants (the “Warrants”) identified in the Prospectus/Offer to Exchange (as defined below). The purpose of.
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) will hold its Q1 2024 Earnings Conference Call on May 15, 2024 at 9:00 AM ET. Participants include Jim Young, Mary Szela, Sean Murphy, and Justin Walsh from JonesTrading. Good morning and welcome to the TriSalus Life Sciences First Quarter 2024 Earnings Conference Call.
TriSalus Life Sciences® Inc., an oncology company combining its unique delivery technology with immunotherapy to revolutionize treatment for patients with liver and pancreatic tumors, will hold a conference call and webcast on May 15, 2024, at 9:00 a.m. ET to review financial results for the first quarter ending March 31, 2024, and offer a business update. A press release with the first quarter results will be released beforehand.
DENVER--(BUSINESS WIRE)--TriSalus Life Sciences® Inc. (Nasdaq: TLSI) announced today that the Company will host a conference call and webcast on April 1, 2024, at 9:00 a.m. ET to discuss financial results for the fourth quarter and full year ended December 31, 2023, and provide a business update. A press release detailing the fourth quarter and full year results will be issued prior to the call. Preliminary, Unaudited Fourth Quarter and Full Year 2023 Financial Results Full financial results fo.
What type of business is TriSalus Life Sciences?
TriSalus Life Sciences, Inc., an immunotherapy company that develops and commercializes immunotherapies for the treatment of liver and pancreatic tumors. The company offers the TriNav Infusion System for hepatic arterial infusion of liver tumors; and the Pancreatic Retrograde Venous Infusion System for pancreatic tumors. It also develops SD-101, an investigational immunotherapeutic with pressure-enabled drug delivery technology for hepatocellular carcinoma, intrahepatic cholangiocarcinoma, uveal melanoma with liver metastases, pancreatic ductal adenocarcinoma with liver metastases, colorectal cancer with liver metastases, and primary pancreatic cancers. The company is based in Westminster, Colorado.
What sector is TriSalus Life Sciences in?
TriSalus Life Sciences is in the Healthcare sector
What industry is TriSalus Life Sciences in?
TriSalus Life Sciences is in the Medical Devices industry
What country is TriSalus Life Sciences from?
TriSalus Life Sciences is headquartered in United States
When did TriSalus Life Sciences go public?
TriSalus Life Sciences initial public offering (IPO) was on 08 February 2021
What is TriSalus Life Sciences website?
https://trisaluslifesci.com
Is TriSalus Life Sciences in the S&P 500?
No, TriSalus Life Sciences is not included in the S&P 500 index
Is TriSalus Life Sciences in the NASDAQ 100?
No, TriSalus Life Sciences is not included in the NASDAQ 100 index
Is TriSalus Life Sciences in the Dow Jones?
No, TriSalus Life Sciences is not included in the Dow Jones index
When does TriSalus Life Sciences report earnings?
The next expected earnings date for TriSalus Life Sciences is 30 August 2024